VISTAGEN THERAPEUTICS, INC. Contract Liability (Deferred Revenue)
VISTAGEN THERAPEUTICS, INC. (VTGN) had Contract Liability (Deferred Revenue) of $234.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Liability, Current $234.00K.
- 2026-03-31: Contract with Customer, Liability, Current $1.71M.
- 2025-12-31: Contract with Customer, Liability, Current $2.00M.
- 2025-09-30: Contract with Customer, Liability, Current $2.14M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $234.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.71M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.00M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $2.14M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.51M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.59M 10-K · filed 2026-06-15 | |
| 2024-12-31 | $2.51M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $2.47M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $791.00K 10-K · filed 2025-06-17 | |
| 2023-12-31 | $1.76M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $793.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $714.30K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $714.00K 10-K · filed 2024-06-11 | $714.30K 10-K · filed 2023-06-28 |
| 2022-12-31 | $712.30K 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $712.30K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.24M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.24M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $1.42M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $1.42M 10-Q · filed 2021-11-10 | |
| 2021-03-31 | $1.42M 10-K · filed 2022-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |